Skip to content

The effectiveness of a tailored intervention program on return-to-work in unemployed sick-listed cancer patients and survivors: A randomized controlled trial.

The effectiveness of a tailored intervention program on return-to-work in unemployed sick-listed cancer patients and survivors: A randomized controlled trial. - RE-CAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39528
Enrollment
164
Registered
2013-01-15
Start date
2013-05-10
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Malignities

Interventions

The tailored intervention program starts with an introductory interview with the unemployed employee (further referred to as *participant*). During the interview, the tailored intervention program w

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients and survivors are eligible to participate in this study, when they are between 18 and 60 years old, when they have a primary diagnosis of cancer and when this diagnosis is registered at UWV, as the main cause for their sick-leave. Furthermore, they must be registered at UWV as a social security safety netter without an employment contract; they must have applied for a sickness benefit and they must be at sick leave for at least 6 months up to 60 months. Patients will be included if they finished intensive cancer treatment at least 6 weeks prior to the start of this study (based on self-report by the patient), if their health status allows them to participate in the study (based on self-report by the patient) and if there are no comorbidities of such extent (e.g., severe psychological or physical conditions) that would interfere with participating in this study (based on report from the patient*s general practitioner). In case a patient is still undergoing intensive (cancer) treatment (chemotherapy, radiotherapy, surgery or another type of intensive curative treatment), he/she will be included at a minimum of 6 weeks after finishing these treatments. Patients who are scheduled to undergo such treatments within the next 6 months will also be held to this criterion.

Exclusion criteria

Exclusion criteria: Patients will be excluded in case of comorbidity of such kind that participating in the tailored intervention program is not possible, in case of serious psychiatric disorders, in case of pregnancy, in case of a lack of knowledge of the Dutch language and/or in case of a conflict with UWV regarding a (previous) sickness benefit claim or a long-term disability claim. Additionally, patients will be excluded if they are participating or signed up to be participating in a concurrent scientific study and/or re-integration/rehabilitation program.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is duration until sustainable RTW after sick leave, calculated as the number of days between the first date of sick leave and the first day the participant returns to work. Any kind of paid work or work resumption with ongoing benefits will be qualified as a return to work.

Secondary

MeasureTime frame
Rate of return-to-work during follow-up, readiness to return to work, fatigue, psychological distress, general participation in society, coping, general health and health related quality of life. Other parameters are: socio-demographic factors, co-morbidity, questions regarding cancer diagnosis and treatment, work-related questions.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)